TCBPW Projected Dividend Yield
Wt Pur Sponsored ADR/TC BioPharm (Holdings) plc ( NASDAQ : TCBPW )TC BioPharm is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products based on Co.'s proprietary allogeneic gamma delta T (GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled Co. to develop a range of clinical-stage cell therapies designed to combat cancer and viral infection. In addition to unmodified allogenic GD-Ts for treatment of blood cancers, Co. also is developing an innovative range of genetically-modified CAR-T products for treatment of solid cancers. 20 YEAR PERFORMANCE RESULTS |
TCBPW Dividend History Detail TCBPW Dividend News TCBPW Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |